{"log_id": 5554596104723744866, "direction": 0, "words_result_num": 93, "words_result": [{"probability": {"variance": 0.019761, "average": 0.925645, "min": 0.378267}, "location": {"width": 1930, "top": 71, "height": 51, "left": 85}, "words": "为生殖器疱疹是性传插疾病,患者应免接触患者,并性交,以免感染配偶。生殖器疱疹也能在没有症状时传染,通过无症状的病"}, {"probability": {"variance": 0.020961, "average": 0.906274, "min": 0.476338}, "location": {"width": 1930, "top": 117, "height": 42, "left": 85}, "words": "毒排出,如果发坝生殖酱疱疹复发,病人应该在发现第一个症状或体征时立即治疗。由于生殖器疱疹患者大多数容易患官颈癌,因此患"}, {"probability": {"variance": 0.011435, "average": 0.962909, "min": 0.558251}, "location": {"width": 503, "top": 154, "height": 40, "left": 85}, "words": "者至少应一年检查一次,以早期发现"}, {"probability": {"variance": 0.025485, "average": 0.921711, "min": 0.386313}, "location": {"width": 1859, "top": 185, "height": 45, "left": 157}, "words": "9,严重免疫功能缺陷者长期应用本品治疗后可能会引起耐药。如果单疱疹患者应用本品后皮肤报害不见改善者应当测试病对本品"}, {"probability": {"variance": 0.027097, "average": 0.902285, "min": 0.617172}, "location": {"width": 125, "top": 234, "height": 34, "left": 85}, "words": "的教感性"}, {"probability": {"variance": 0.019484, "average": 0.933858, "min": 0.377115}, "location": {"width": 1859, "top": 260, "height": 45, "left": 157}, "words": ".静脉滴注时宜级慢,否则可发生肾小管内药物结品淀,引起肾功能损害凶病例可达10,并勿使之漏至血外,以免引起及"}, {"probability": {"variance": 0.002677, "average": 0.93471, "min": 0.864496}, "location": {"width": 97, "top": 303, "height": 40, "left": 85}, "words": "静脉炎"}, {"probability": {"variance": 0.017559, "average": 0.922336, "min": 0.495821}, "location": {"width": 1255, "top": 334, "height": 42, "left": 157}, "words": "11.静脉滴注后2小时,尿药浓度最高,此时应给疗人充足的水,防上药物沉积于肾小管内"}, {"probability": {"variance": 0.026752, "average": 0.892823, "min": 0.356701}, "location": {"width": 1184, "top": 369, "height": 45, "left": 157}, "words": "2、一次血透桥使血药浓度降低60元、故每次血液透析6小时应重复补一次剂盘"}, {"probability": {"variance": 0.023277, "average": 0.930883, "min": 0.441791}, "location": {"width": 1129, "top": 409, "height": 40, "left": 160}, "words": "13,肥胖患者的剂量应标准体重计算。需要剂量调整时,可根据肌酐清除率调整"}, {"probability": {"variance": 0.023888, "average": 0.918962, "min": 0.42946}, "location": {"width": 1418, "top": 446, "height": 40, "left": 157}, "words": "14、对断的干扰:可引起肾小管阻塞,使血肌酐和尿就氢增高。如剂量恰当、水分充一般不会引起"}, {"probability": {"variance": 0.018409, "average": 0.928798, "min": 0.45931}, "location": {"width": 1047, "top": 480, "height": 40, "left": 157}, "words": "15.本剂呈碱性,与其他药物混合容引起pH改变,应尽量延免配伍使用"}, {"probability": {"variance": 0.035413, "average": 0.874868, "min": 0.401464}, "location": {"width": 1842, "top": 517, "height": 45, "left": 157}, "words": "t、人须知:果感到有严重或令人烦恼的不反起,已怀孕或备怀者,准备哺乳的妇女,或有其它问题的病人,应咨询医生"}, {"probability": {"variance": 0.017301, "average": 0.956492, "min": 0.540566}, "location": {"width": 349, "top": 552, "height": 42, "left": 85}, "words": "在医生的指导下合理用药"}, {"probability": {"variance": 0.014018, "average": 0.947673, "min": 0.469693}, "location": {"width": 635, "top": 592, "height": 37, "left": 217}, "words": "溶解后,如遇变色,结品、浑浊、异物应禁用"}, {"probability": {"variance": 0.011885, "average": 0.956129, "min": 0.519516}, "location": {"width": 1839, "top": 626, "height": 45, "left": 177}, "words": "孕妇及哺乳期妇女用药】孕妇用。从1984年至1994年4日建立的一项关于妇使用青洛韦的疗效的流行病学记录,在为3个月的"}, {"probability": {"variance": 0.017813, "average": 0.937452, "min": 0.36661}, "location": {"width": 1916, "top": 663, "height": 40, "left": 94}, "words": "5项空验结果中有749名孕妇先后系统服用阿背书,其对婴儿的商作用近似于普通人群。但这些数据尚不足以证明阿昔洛韦对孕妇和"}, {"probability": {"variance": 0.014991, "average": 0.945326, "min": 0.439815}, "location": {"width": 1270, "top": 698, "height": 42, "left": 82}, "words": "胎儿是安全的。只有当网昔洛书对胎儿的治疗作用远大于其风险时才可以考虑用阿昔洛"}, {"probability": {"variance": 0.018102, "average": 0.928715, "min": 0.439048}, "location": {"width": 1865, "top": 738, "height": 42, "left": 151}, "words": "阿昔洛书在乳汁中的浓度为血药浓度的06一4.1倍:当哺乳期妇女服药剂量达到每天03mgkg时将n能影响婴儿的发育。只有在必情"}, {"probability": {"variance": 0.025863, "average": 0.916896, "min": 0.48237}, "location": {"width": 514, "top": 778, "height": 37, "left": 82}, "words": "况下:哺乳期妇女才可使用阿昔洛韦"}, {"probability": {"variance": 0.02327, "average": 0.925982, "min": 0.381595}, "location": {"width": 1830, "top": 809, "height": 42, "left": 180}, "words": "儿童用药儿童中虽未发现特殊不良反应,但应慎用。新生儿不宜用含笨甲醇的稀释液配制注液,否则易引起致命性的综合征,包"}, {"probability": {"variance": 0.040077, "average": 0.86068, "min": 0.351761}, "location": {"width": 1058, "top": 852, "height": 37, "left": 74}, "words": "括酸中毒中柜漳制、呼因誹,肾功能衰竭、低血压、痫和颅内出重等"}, {"probability": {"variance": 0.009008, "average": 0.954243, "min": 0.608769}, "location": {"width": 1284, "top": 881, "height": 45, "left": 177}, "words": "老年用药丨日前尚无充分的研究资料表叫对65岁以上老年人的月药与年轻人的用药有明显不同"}, {"probability": {"variance": 0.035662, "average": 0.887298, "min": 0.384514}, "location": {"width": 474, "top": 881, "height": 42, "left": 1536}, "words": "般情况来说,老年人用药应小心"}, {"probability": {"variance": 0.01552, "average": 0.947112, "min": 0.448903}, "location": {"width": 1384, "top": 918, "height": 42, "left": 74}, "words": "慎,选择低充量的有效服药范围,尽量降低因增加服药次数而造成的肾功能减退或其他副反应的发生"}, {"probability": {"variance": 0.019697, "average": 0.929717, "min": 0.395985}, "location": {"width": 1152, "top": 955, "height": 42, "left": 177}, "words": "药物相互作用1,与干扰素或甲氨累(销内)合用,可能引起精神异常,应慎用"}, {"probability": {"variance": 0.006147, "average": 0.960576, "min": 0.71909}, "location": {"width": 929, "top": 995, "height": 37, "left": 160}, "words": "2、与肾毒性药物合用可加重肾毒性,特别是肾功能不全者更发生"}, {"probability": {"variance": 0.018583, "average": 0.881587, "min": 0.671516}, "location": {"width": 203, "top": 1038, "height": 31, "left": 160}, "words": "3.与齐多夫定"}, {"probability": {"variance": 0.017403, "average": 0.910844, "min": 0.514027}, "location": {"width": 700, "top": 1032, "height": 40, "left": 489}, "words": "dine)合用可引起肾毒性,表现为深度昏睡和疲劳"}, {"probability": {"variance": 0.026019, "average": 0.912389, "min": 0.397465}, "location": {"width": 1364, "top": 1064, "height": 45, "left": 208}, "words": "与丙舒竞争性掉制有机酸分泌,合并用磺舒可使品的排泄减慢,半衰期延长,体内药物蓄积"}, {"probability": {"variance": 0.021695, "average": 0.923935, "min": 0.376085}, "location": {"width": 1836, "top": 1101, "height": 40, "left": 177}, "words": "药物过量1用剂量大于20克,可致兴奋、动、香迷、震、无力,快速静脉注射给予过高的剂量,阿昔洛韦会因其在肾小管中浓"}, {"probability": {"variance": 0.027229, "average": 0.929872, "min": 0.493844}, "location": {"width": 248, "top": 1144, "height": 37, "left": 85}, "words": "度过大而结晶沉淀"}, {"probability": {"variance": 0.023248, "average": 0.90931, "min": 0.361582}, "location": {"width": 1487, "top": 1138, "height": 42, "left": 529}, "words": "导致由千肌、肌及血尿素氮升高面继发引起的肾衰:一旦发生肾衰及无尿症,病人须作血液透析直至肾"}, {"probability": {"variance": 0.001688, "average": 0.971167, "min": 0.900255}, "location": {"width": 125, "top": 1178, "height": 40, "left": 85}, "words": "功能恢复"}, {"probability": {"variance": 0.016083, "average": 0.92008, "min": 0.366233}, "location": {"width": 1859, "top": 1210, "height": 45, "left": 151}, "words": "【药理奇理药作用本品为合成的核苷类抗病毒药,体内和体外对单纯性疱病毒I型(HSV-1)、型(HSV-2)及水痘-带状疱"}, {"probability": {"variance": 0.027244, "average": 0.897348, "min": 0.360356}, "location": {"width": 895, "top": 1250, "height": 40, "left": 82}, "words": "岗毒(YZ)均有神制作用细胞培养结果表明,本品对神制"}, {"probability": {"variance": 0.020936, "average": 0.886217, "min": 0.543381}, "location": {"width": 606, "top": 1252, "height": 34, "left": 1067}, "words": "病毒的作用最强,其次为HSV-2和VZV病毒"}, {"probability": {"variance": 0.023425, "average": 0.904703, "min": 0.367381}, "location": {"width": 1865, "top": 1281, "height": 45, "left": 154}, "words": "由于本品对由 ISVRNZV编码的苷缴酶(TK)具有亲和力,使得其具有高选择性的抑制作用。此类病毒酶将阿洛书转化戒阿昔洛韦"}, {"probability": {"variance": 0.02801, "average": 0.899847, "min": 0.359449}, "location": {"width": 1928, "top": 1318, "height": 42, "left": 88}, "words": "单磷酸盐,即核苷类似物。单醛盐进一步被细胞中的乌背酸激酶转化成二磷盐,再通过细胞中的多种酶转变为三磷酸在体外,阿昔"}, {"probability": {"variance": 0.019565, "average": 0.941555, "min": 0.500147}, "location": {"width": 838, "top": 1361, "height": 40, "left": 82}, "words": "洛书三磷酸盐中让疱痿病毒DNA复制是由以下三种方式完成"}, {"probability": {"variance": 0.002349, "average": 0.982107, "min": 0.740879}, "location": {"width": 969, "top": 1355, "height": 42, "left": 1024}, "words": "竞争性地抑制病毒DNA聚合酶;(2)进入并终止延长的病毒DNA链"}, {"probability": {"variance": 0.032796, "average": 0.880273, "min": 0.37052}, "location": {"width": 1650, "top": 1393, "height": 48, "left": 165}, "words": "灭活病毒DNA聚合酶与vZY相比。本品对HSV的抗病孝活性更强,这是因为病毒的胸苷微(TK)的化作用更强"}, {"probability": {"variance": 0.031714, "average": 0.908397, "min": 0.373093}, "location": {"width": 1865, "top": 1430, "height": 42, "left": 154}, "words": "毒研究遗传意性:进行了6项传毒性试验,在专项微生物研究中见致突变作用;在小鼠淋巴细胞和人淋巴细胞上进行的2项"}, {"probability": {"variance": 0.019154, "average": 0.9257, "min": 0.467039}, "location": {"width": 1930, "top": 1467, "height": 40, "left": 85}, "words": "外细透传试验结果表明,本品具有致突变作用在5项体外细胞遗传试验3项为中国仓鼠的卵巢胞.2项为小鼠淋巴瘤细胞)中,未"}, {"probability": {"variance": 0.01101, "average": 0.953422, "min": 0.458288}, "location": {"width": 1930, "top": 1504, "height": 40, "left": 88}, "words": "见致突变作月。在免疫功能不全的,正断乳的、同源的幼鼠给药后所进行的2次体外细胞转化试验中,其中1次结果为阳性,可见细胞从形"}, {"probability": {"variance": 0.021604, "average": 0.91036, "min": 0.382023}, "location": {"width": 1167, "top": 1541, "height": 42, "left": 85}, "words": "上转变为肿瘤细胞,而在另一试验中,则未见同样的结果(原因可能是感性较低"}, {"probability": {"variance": 0.009969, "average": 0.959989, "min": 0.50087}, "location": {"width": 692, "top": 1541, "height": 37, "left": 1324}, "words": "以人用药剂量的3B0-760倍给于中国仓鼠时,可引"}, {"probability": {"variance": 0.022997, "average": 0.924507, "min": 0.367012}, "location": {"width": 1913, "top": 1576, "height": 48, "left": 85}, "words": "起染色体损伤;面大量以62~125倍剂量药时,色体的损伤无明显变化:小鼠的显性致死试验(在人用剂量的36-73倍剂量下结果为阴性"}, {"probability": {"variance": 0.030332, "average": 0.878133, "min": 0.465608}, "location": {"width": 414, "top": 1621, "height": 34, "left": 165}, "words": "主殖毒性:小鼠〔450mg/kg/天"}, {"probability": {"variance": 0.025534, "average": 0.910317, "min": 0.428738}, "location": {"width": 1318, "top": 1613, "height": 51, "left": 689}, "words": "和家兔(25mg/kg天,SC)试验结果表明,本品对其生育力和生殖功能无影响小和大星的血"}, {"probability": {"variance": 0.028668, "average": 0.886266, "min": 0.413511}, "location": {"width": 1287, "top": 1647, "height": 42, "left": 85}, "words": "浆药物浓度分别为人体血药水平的~18倍和8-15倍,大鼠和家兔哈予更高剂量(50mg/lkg/天"}, {"probability": {"variance": 0.006295, "average": 0.959076, "min": 0.713084}, "location": {"width": 526, "top": 1653, "height": 34, "left": 1456}, "words": "分别为入用水平的11-22倍和16-31倍"}, {"probability": {"variance": 0.02383, "average": 0.908309, "min": 0.39463}, "location": {"width": 1928, "top": 1690, "height": 37, "left": 85}, "words": "时,可降低着床,不影响同窝仔的大小大鼠在产前产后服用本品(50 nging天,SC),间平均黄体、总着床位置和活存胎儿等均"}, {"probability": {"variance": 0.009785, "average": 0.940025, "min": 0.689989}, "location": {"width": 349, "top": 1724, "height": 42, "left": 88}, "words": "有计学意义的明显下降"}, {"probability": {"variance": 0.022917, "average": 0.900637, "min": 0.359873}, "location": {"width": 1467, "top": 1762, "height": 40, "left": 157}, "words": "犬连个月予本品(50mg/kg/无,IV,为人用剂量的21~41倍1血药浓度为人的21-41倍)或连续l年"}, {"probability": {"variance": 0.000595, "average": 0.973532, "min": 0.932916}, "location": {"width": 74, "top": 1762, "height": 34, "left": 1747}, "words": "kg/天"}, {"probability": {"variance": 1e-06, "average": 0.998479, "min": 0.997555}, "location": {"width": 62, "top": 1762, "height": 34, "left": 1950}, "words": "为人"}, {"probability": {"variance": 0.013473, "average": 0.946356, "min": 0.43515}, "location": {"width": 1524, "top": 1799, "height": 40, "left": 88}, "words": "用剂量的6-12倍,结果均未发现睾丸异常在大自和犬的更高剂量给药时,可见丸萎缩和精子减少。小鼠"}, {"probability": {"variance": 0.020544, "average": 0.896902, "min": 0.538666}, "location": {"width": 286, "top": 1799, "height": 34, "left": 1722}, "words": "g/kg/天,Po),家兔"}, {"probability": {"variance": 0.016851, "average": 0.915125, "min": 0.588072}, "location": {"width": 409, "top": 1839, "height": 37, "left": 134}, "words": "0mg/kg/天,SC或V)和大鼠"}, {"probability": {"variance": 0.012223, "average": 0.943986, "min": 0.539164}, "location": {"width": 740, "top": 1830, "height": 51, "left": 629}, "words": "gkg/天,Sc)的所给予的暴露剂量分别为人用剂量的"}, {"probability": {"variance": 0.039324, "average": 0.858116, "min": 0.460569}, "location": {"width": 320, "top": 1833, "height": 40, "left": 1693}, "words": "倍时,结果均未见玫崎"}, {"probability": {"variance": 0.022763, "average": 0.847756, "min": 0.696883}, "location": {"width": 68, "top": 1873, "height": 34, "left": 85}, "words": "作用"}, {"probability": {"variance": 0.015587, "average": 0.929309, "min": 0.51747}, "location": {"width": 1862, "top": 1905, "height": 42, "left": 157}, "words": "在孕妇中尚无充分的和严格对照的研究,但是有一行病学调查明,追踪了7三6名孕妇全身用药,对婴儿的出生缺陷发生率近似于普"}, {"probability": {"variance": 0.009528, "average": 0.958145, "min": 0.493409}, "location": {"width": 1742, "top": 1939, "height": 51, "left": 88}, "words": "通人群。但这些据尚不足以证明其对孕妇和胎儿是安全的。只有当本品对胎儿的冶疗作用远大于其风险时,才可以考虚服用"}, {"probability": {"variance": 0.013523, "average": 0.945813, "min": 0.403951}, "location": {"width": 1839, "top": 1979, "height": 42, "left": 154}, "words": "哺乳期妇女用药,本品在乳汁中的度为其血药浓度的06~4.1倍,当乳期妇女服药剂量达到0.3mg/kg/天时,该浓度可能累及婴儿"}, {"probability": {"variance": 0.000553, "average": 0.987717, "min": 0.896598}, "location": {"width": 792, "top": 2019, "height": 34, "left": 85}, "words": "所以哺乳期妇女使用时应谨,并只有在必要时才可使用"}, {"probability": {"variance": 0.023325, "average": 0.919446, "min": 0.368996}, "location": {"width": 1870, "top": 2048, "height": 48, "left": 151}, "words": "致癌性:在大鼠和小鼠的整个生命期,通过管给予品450mgkg,结果表明,给药对照组间发生肿的动物紫的别无统计学意"}, {"probability": {"variance": 0.023597, "average": 0.893577, "min": 0.530847}, "location": {"width": 1373, "top": 2085, "height": 42, "left": 91}, "words": "又,也不缩短肿瘤发生的潜伏期,小鼠和大鼠的量大血浆浓度分别为人用剂量水平的3~6倍和1-2倍"}, {"probability": {"variance": 0.016797, "average": 0.920783, "min": 0.469974}, "location": {"width": 1842, "top": 2119, "height": 45, "left": 177}, "words": "药代动力学】阿昔洛书能广泛分布至各组织与体液中,包括,肾、帥、肝、小肠、肌肉、胆、乳汁,子、阴道精膜与分泌物、脑"}, {"probability": {"variance": 0.022741, "average": 0.919753, "min": 0.411324}, "location": {"width": 1933, "top": 2159, "height": 40, "left": 85}, "words": "脊及疱洁。在肾、肝和小肠中浓度高,脑脊液中浓度约为血中浓度的一半。药物可通过胎盘、健康成人楼5mg/kg和10mg/kg萨滴注"}, {"probability": {"variance": 0.022086, "average": 0.91701, "min": 0.386108}, "location": {"width": 1902, "top": 2199, "height": 40, "left": 108}, "words": "小时后,平均稳态自浓度分别为98μgml和20.7μg/ml.小时后谷浓分别为0.μgm1和2.3μ giml a一岁以上儿童,用最为250mg/m"}, {"probability": {"variance": 0.019893, "average": 0.920992, "min": 0.438532}, "location": {"width": 1933, "top": 2234, "height": 45, "left": 85}, "words": "者,其血药浓度变化与成人5mg/kg相近,面用量500mg/m2与人10mg/kg用墅者相近,新生儿(3月以下)每小时静脉满注mgkg,每"}, {"probability": {"variance": 0.008275, "average": 0.951768, "min": 0.656505}, "location": {"width": 474, "top": 2274, "height": 34, "left": 88}, "words": "次滴注持续1小时,其稳峰浓度"}, {"probability": {"variance": 0.028647, "average": 0.883507, "min": 0.379253}, "location": {"width": 500, "top": 2271, "height": 40, "left": 703}, "words": "为13.8μg/ml而谷浓度则为"}, {"probability": {"variance": 0.011222, "average": 0.949108, "min": 0.477033}, "location": {"width": 752, "top": 2271, "height": 40, "left": 1267}, "words": "本品的蛋白结合率低(9%一33%)。在肝内代谢,主要"}, {"probability": {"variance": 0.018158, "average": 0.923034, "min": 0.440078}, "location": {"width": 1928, "top": 2308, "height": 40, "left": 91}, "words": "代谢物占维药量的9凭-14%,尿排泄,血销除半衰期(1:)约为2.5小时。酐清除率50-80ml/分钟和15~50m1/分钟时,血消除半衰期"}, {"probability": {"variance": 0.030972, "average": 0.870888, "min": 0.371872}, "location": {"width": 703, "top": 2348, "height": 37, "left": 191}, "words": "分别为3,1小时和3.5小时无者的血除半衰期"}, {"probability": {"variance": 0.025329, "average": 0.913813, "min": 0.395979}, "location": {"width": 1015, "top": 2342, "height": 40, "left": 1004}, "words": "长达19.3小时,血液析时降为5.7小时本品主要经肾出肾小球滤过和肾"}, {"probability": {"variance": 0.037049, "average": 0.88338, "min": 0.374337}, "location": {"width": 1047, "top": 2380, "height": 40, "left": 85}, "words": "小管分泌而排。约45一79%的药牧以形由泄,经粪便排泄率低于"}, {"probability": {"variance": 0.020663, "average": 0.911976, "min": 0.443418}, "location": {"width": 815, "top": 2385, "height": 34, "left": 1207}, "words": "呼出气中含量药物。血液透析h小时约清除血中60%的药"}, {"probability": {"variance": 0.031903, "average": 0.921072, "min": 0.367375}, "location": {"width": 354, "top": 2420, "height": 37, "left": 82}, "words": "物。腹膜透析除量很少"}, {"probability": {"variance": 0.048113, "average": 0.864317, "min": 0.366114}, "location": {"width": 320, "top": 2457, "height": 34, "left": 177}, "words": "贮遮光,密保存"}, {"probability": {"variance": 0.014951, "average": 0.916139, "min": 0.477875}, "location": {"width": 1421, "top": 2491, "height": 40, "left": 180}, "words": "包装】低硅璃管制注射剂期一注射用无菌粉末用卤化丁基橡胶塞一抗生素瓶用铝塑组合益;每盒10瓶"}, {"probability": {"variance": 0.050123, "average": 0.848714, "min": 0.403933}, "location": {"width": 220, "top": 2531, "height": 37, "left": 180}, "words": "有效期21个月"}, {"probability": {"variance": 0.005985, "average": 0.963488, "min": 0.698376}, "location": {"width": 543, "top": 2563, "height": 40, "left": 177}, "words": "执行标准】中国药典多2013年版二部"}, {"probability": {"variance": 0.002522, "average": 0.93733, "min": 0.839139}, "location": {"width": 294, "top": 2606, "height": 31, "left": 174}, "words": "批准立号】国药准字"}, {"probability": {"variance": 0.000599, "average": 0.974827, "min": 0.934771}, "location": {"width": 123, "top": 2637, "height": 31, "left": 180}, "words": "生产企业"}, {"probability": {"variance": 0.020627, "average": 0.926149, "min": 0.585158}, "location": {"width": 540, "top": 2671, "height": 40, "left": 157}, "words": "企业名称;国药梨团容生制药有限公司"}, {"probability": {"variance": 0.000464, "average": 0.986478, "min": 0.932602}, "location": {"width": 534, "top": 2709, "height": 40, "left": 157}, "words": "生产地址:河南省武县东三环路中段"}, {"probability": {"variance": 0.013802, "average": 0.904032, "min": 0.682202}, "location": {"width": 246, "top": 2751, "height": 28, "left": 157}, "words": "哪政蛋码:15495"}, {"probability": {"variance": 0.000904, "average": 0.971783, "min": 0.929997}, "location": {"width": 128, "top": 2783, "height": 37, "left": 157}, "words": "电话号"}, {"probability": {"variance": 0.015694, "average": 0.894061, "min": 0.660344}, "location": {"width": 188, "top": 2817, "height": 40, "left": 151}, "words": "传号码:0"}], "language": -1}